Raxbery Pharmaceuticals Private Limited

Raxbery Pharmaceuticals Private Limited - construction in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U45100KA2013PTC068988 Incorporated 08 May 2013 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company construction
Revenue · FY 2021
₹25.5 Lakh
▼ 55% YoY
Net loss · FY 2021
₹50,997
Net margin -2%
EBITDA · FY 2021
-₹50,732
EBITDA margin -2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Raxbery Pharmaceuticals Private Limited

Data last updated:

Raxbery Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the site preparation segment of the construction sector. It was incorporated on 08 May 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U45100KA2013PTC068988. Its GSTIN is 29AAGCR3797L1ZI (Karnataka).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Ravindran Peedigial (Managing Director) and Shujing Ye.

Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at #13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068.

As per the financials filed for FY 2021, the company reported a revenue of ₹25.5 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹50,997 (net margin -2%) and EBITDA of -₹50,732 (EBITDA margin -2%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U45100KA2013PTC068988
Registration Number 068988
Incorporation Date 08 May 2013
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Raxbery Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900KA2013PTC068988. The current CIN is U45100KA2013PTC068988, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U45100KA2013PTC068988Current
U74900KA2013PTC068988Previous

Contact details

Raxbery Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    #13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068
  • Industry
    Construction, Site Preparation

To see the full contact details of Raxbery Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Raxbery Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Raxbery Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Raxbery Pharmaceuticals Private Limited, buy the company report.

Financials of Raxbery Pharmaceuticals Private Limited

FY 2021 filings available

Raxbery Pharmaceuticals Private Limited reported revenue of ₹25.5 Lakh (down 55% YoY) for FY 2021.

Revenue · FY 2021
₹25.5 Lakh ▼ 55%
Net loss · FY 2021
₹50,997 margin -2%
EBITDA · FY 2021
-₹50,732 margin -2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 32%

Revenue has declined at a compounded annual rate (CAGR) of 11% over three years, including a 55% fall in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹50,732
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹50,997
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-2%
Net Profit Margin-2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raxbery Pharmaceuticals Private Limited, buy the company report.

Board of directors of Raxbery Pharmaceuticals Private Limited

Raxbery Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manoj Ravindran PeedigialManaging Director08 May 201313 Years 6 MonthsCurrent
Shujing YeDirector12 Nov 201610 Years 0 MonthsCurrent

Auditor

Raxbery Pharmaceuticals Private Limited is audited by KPMS & Associates for the financial year 2017.

Auditor firmFinancial yearFirm registration number
KPMS & AssociatesFY 2017012090S

Shareholding

The shareholding of Raxbery Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Raxbery Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raxbery Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raxbery Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAGCR3797L1ZIKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Raxbery Pharmaceuticals Private Limited, buy the company report.

Recent activity

Raxbery Pharmaceuticals Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Shujing Ye was appointed as Director on 12 Nov 2016.

AGM
Raxbery Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Raxbery Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore.
Appointed
Shujing Ye was appointed as Director.
Ceased
Vijayammal ceased to be Director.
Ceased
Lakshmi Yadla ceased to be Director.
Appointed
Manoj Ravindran Peedigial was appointed as Managing Director.
Incorporation
08 May 2013
Raxbery Pharmaceuticals Private Limited was registered on 08 May 2013 with Roc Bangalore & aged 13 years 6 months as per MCA records.

Frequently asked questions

Raxbery Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in site preparation, within the construction industry. It was incorporated on 08 May 2013 (13+ years old) and is registered under CIN U45100KA2013PTC068988.

Raxbery Pharmaceuticals has 2 current directors:

The latest financial statements of Raxbery Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Raxbery Pharmaceuticals is 29AAGCR3797L1ZI, registered in Karnataka.

The CIN (Corporate Identification Number) of Raxbery Pharmaceuticals is U45100KA2013PTC068988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raxbery Pharmaceuticals was incorporated on 08 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.

Shujing Ye was appointed as Director on 12 Nov 2016. Vijayammal ceased to be Director on 01 Nov 2016. Lakshmi Yadla ceased to be Director on 22 Apr 2016. Raxbery Pharmaceuticals has 4 board changes on record in total.

The registered office of Raxbery Pharmaceuticals is at #13 4th Cross 1st Main Hosaplaya Madiwala Post Bommanahalli, Bangalore, Karnataka, India – 560068.

Raxbery Pharmaceuticals operates in the construction industry, in the site preparation segment.

The compliance status of Raxbery Pharmaceuticals is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.